Texas Tech University Health Sciences Center

TTUHSC Medical Students Educate about COVID-19 Vaccination Misconceptions with Outreach to Hispanic Communities

Newswise — According to the Centers for Disease Control and Prevention (CDC), Hispanics are twice as likely to die from COVID-19 than non-Hispanic whites. Despite higher rates of infection and death from COVID-19, the CDC report showed minorities are getting vaccinated at disproportionately lower rates compared to non-Hispanic whites. In a CDC report of demographic characteristics of persons vaccinated during the first months of the COVID-19 Vaccination Program, U.S. Latinos received about 11.5% of the vaccinations, while Non-Hispanic white people received more than 60% of the vaccines.

To help address this disparity, student members of the Texas Tech University Health Sciences Center (TTUHSC) Latino Medical Student Association (LMSA) answered questions and myths about the COVID-19 vaccine for the Hispanic community April 17 at Amigos United Supermarket in Lubbock.

Luis Castro, second-year TTUHSC School of Medicine student and LMSA vice president, said misinformation and lack of vaccine knowledge could be one reason for low vaccination rates in these demographics.

“Many in our communities may have misconceptions about the COVID-19 vaccine or just don’t know who to ask about any fears they have,” Castro said. LMSA exists to unite and empower medical students through service and mentorship. Castro said the TTUHSC School of Medicine chapter wants to advocate for the health of the Latino community, especially during this pandemic. This was the first of many outreach efforts by LMSA.

“Our hope is to go out to communities with Spanish-speaking members and help get some of these questions answered. Once we do that, hopefully they will have the facts and feel better about getting the vaccine to protect themselves and their families.”

Common misconceptions about COVID-19 vaccines are as follows and also included in Spanish:

  • The COVID-19 vaccines are unsafe because they were created too quickly. While it is true that vaccines were developed quickly, they did so without compromising safety. Each vaccine was studied on at least 30,000 volunteers without significant adverse events.
  • The vaccines will make me sick! None of the currently approved vaccines carry the live virus. Therefore, the vaccine cannot make you sick. Pain at site of injection is normal, along with fever and chills, tiredness, muscle aches and a headache. The effects are temporary, and it does not mean you have COVID-19.
  • I can avoid getting COVID-19 by taking Vitamin C, Zinc and herbal teas. While it is true that taking vitamins and natural supplements can boost your immune system and protect you from the virus, there is no evidence they are enough to cure or treat COVID-19.
  • The vaccines can cause infertility. This idea has become very popular in social media but there is no evidence from the clinical trials showing any support for this.
  • Do I need to have health insurance to be eligible to receive the vaccine? No, the vaccine has been purchased by the federal government and is being administered free of cost.
  • Undocumented immigrants are not allowed to be vaccinated. The federal government recognizes it is important for everyone in this country to be vaccinated, regardless of immigration status. U.S. Immigration and Customs Enforcement (ICE) has agreed not to carry out enforcement operations near health care facilities, hospitals, doctor’s offices and vaccination clinics.
  • Getting treated, tested, or vaccinated for COVID-19 will count against me when trying to obtain a Green Card because of the “Public Charge” test. No, getting treated, tested or vaccinated for COVID-19 will not affect your chances of obtaining legal residency. This was announced this on the U.S. Citizenship and Immigration Services website.

Conceptos Erróneos y Comunes Sobre el COVID-19:

  • Las vacunas del COVID-19 no son seguras porque se crearon demasiado rápido. Aunque es cierto que las vacunas se desarrollaron rápidamente, lo hicieron sin comprometer la seguridad. Cada vacuna se estudió en al menos 30,000 voluntarios sin efectos secundarios severos.
  • ¡Las vacunas me enfermarán! Ninguna de las vacunas aprobadas actualmente es portadora del virus vivo. Por lo tanto, la vacuna no puede enfermarlo. Es normal sentir dolor en el lugar de la inyección, fiebre y escalofríos, cansancio, dolores musculares y dolor de cabeza. Los efectos son temporales y no significa que tenga COVID-19.
  • Puedo evitar contraer COVID-19 tomando Vitamina C, Zinc o tés medicinales. Aunque es cierto que tomar vitaminas y suplementos naturales puede estimular su sistema inmunológico y pueden ayudar a protegerlo contra el virus, no hay evidencia que demuestre que sean suficientes tratamiento para COVID-19.
  • Las vacunas pueden causar infertilidad. Esta idea se ha vuelto muy popular en las redes sociales, pero no hay evidencia de estudios clínicos que demuestren apoyo para esta idea.
  • No se permite vacunar a los inmigrantes indocumentados. El gobierno federal reconoce que es importante que todos en este país estén vacunados, independientemente de su status migratorio. ICE acordó no ejecutar redadas de inmigración cerca de instalaciones de atención médica, hospitales, consultorios médicos y clínicas de vacunación.
  • Recibir tratamiento, hacerme la prueba o vacunarme contra el COVID-19 contará en mi contra cuando intente obtener residencia legal debido a la prueba de “Carga Pública.” No, recibir tratamiento, hacerse la prueba o vacunarse contra el COVID-19 no afectará sus posibilidades de obtener residencia legal. USCIS anunció esto en su sitio web.
  • ¿Necesito tener seguro médico para ser elegible para recibir la vacuna? No, la vacuna ha sido comprada por el gobierno federal y se administra gratuitamente.



Filters close

Showing results

110 of 5870
Released: 24-Jun-2021 12:30 PM EDT
A tecnologia de IA e ECG pode descartar rapidamente a infecção por COVID-19, concluiu o estudo da Mayo Clinic
Mayo Clinic

A inteligência artificial (IA) pode oferecer uma maneira de determinar com precisão se uma pessoa não está infectada com a COVID-19. Um estudo retrospectivo internacional descobriu que a infecção pelo SARS-CoV-2, o vírus que causa a COVID-19, cria mudanças elétricas sutis no coração. Um eletrocardiograma (ECG) habilitado com IA pode detectar essas alterações e, potencialmente, ser usado como um teste de triagem rápido e confiável para descartar a infecção por COVID-19.

Released: 24-Jun-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic)的研究发现,AI赋能的心电图技术有可能迅速排除COVID-19感染
Mayo Clinic

AI (人工智能)有可能提供准确判断一个人未感染COVID-19(2019冠状病毒病)的方法。一项国际回顾性研究发现,如果感染了导致COVID-19的SARS-CoV-2病毒,患者的心脏会产生微妙的电学变化。AI赋能的心电图(EKG)可以检测到这些变化,并有望被用于进行快速、可靠的COVID-19筛查检测,以排除COVID-19感染。

Newswise: 200421_Felgner_3205_sz-2-768x496.jpg
Released: 24-Jun-2021 11:50 AM EDT
UCI Professor Wins Spain’s Prestigious Princess of Asturias Award for Scientific Research
University of California, Irvine

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Released: 24-Jun-2021 11:00 AM EDT
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
University of Michigan

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

Newswise: Decoding humans’ survival from coronaviruses
Released: 24-Jun-2021 11:00 AM EDT
Decoding humans’ survival from coronaviruses
University of Adelaide

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2021 4:00 PM EDT Released to reporters: 24-Jun-2021 10:35 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2021 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVIDLockdownSimulations.jpg
Released: 24-Jun-2021 10:00 AM EDT
Pandemic Air Quality Affected By Weather, Not Just Lockdowns
Washington University in St. Louis

Using a diverse set of tools, the lab of Randall Martin shows how the pandemic did – or didn’t – affect levels of particulate matter during COVID lockdowns.

Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.


Showing results

110 of 5870

close
1.36072